The expansion of the cholestatic pruritus market across the US will be driven by the introduction of innovative therapies, Linerixibat, Volixibat, and TH104, among others. Furthermore, the rising prevalence of cholestatic pruritus, driven by increased disease awareness, improved...
Cholestatic Pruritus Market is Predicted to Exhibit Remarkable Growth at a CAGR of 23.4% in the US During the Forecast Period (2025-2034) | DelveInsight
Seeking Alpha / 5 hours ago 1 Views
Comments